Online Only

Lynparza FDA Approved, in Combination With Abiraterone and Prednisone (or Prednisolone), for Metastatic Castration-Resistant Prostate Cancer With BRCA Mutation

Epkinly FDA Approved for Relapsed or Refractory Diffuse Large B-Cell Lymphoma or High-Grade B-Cell Lymphoma

Polivy Received New Indication for First-Line Treatment of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, and High-Grade B-Cell Lymphoma

Business, Original Research

Trends in Utilization, Prices, and Spending for Oral Medications for Breast Cancer Treatment in the US Medicaid Population, 2008-2019

Fatimah Alyam, MS, PhD, Jeff Jianfei Guo, BPharm, PhD

Fatimah Alyami, MS, PhD; Jeff Jianfei Guo, BPharm, PhD

AVBCC 2021 Highlights

The Impact of Telehealth on Cancer Care

AVBCC 2021 Highlights

Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care

AVBCC 2021 Highlights

Drug Price Reform with Value in Mind: Can It Happen?

AVBCC 2021 Highlights

Using Value-Based Contracts to Manage Oncology Costs While Keeping Focus on the Patient

Tabrecta (Capmatinib) First FDA-Approved Drug for Metastatic NSCLC with MET Exon 14 Skipping Mutation

Loretta Fala

Ukoniq (Umbralisib) FDA Approved for Adults with Relapsed or Refractory Marginal-Zone Lymphoma or Follicular Lymphoman

Loretta Fala

1
2

Page 1 of 2
Results 1 - 10 of 14

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.